2CT-5-EtO

2CT-5-EtO, also known as 2-methoxy-4-methylthio-5-ethoxyphenethylamine, is a psychedelic drug of the phenethylamine, 2C, and TWEETIO families related to 2C-T.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

2CT-5-EtO, also known as 2-methoxy-4-methylthio-5-ethoxyphenethylamine, is a psychedelic drug of the phenethylamine, 2C, and TWEETIO families related to 2C-T. It is the derivative of 2C-T in which the methoxy group at the 5 position has been replaced with an ethoxy group. According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, 2CT-5-EtO's dose is 30 mg orally and its duration is perhaps 15 hours.

The effects of 2CT-5-EtO have been reported to include body awareness and modest closed-eye visuals, with the experience being described as quiet, peaceful, contemplative, and insightful. Other effects included insomnia and lots of dreams during sleep. The chemical synthesis of 2CT-5-EtO has been described.

2CT-5-EtO was first described in the literature by Shulgin in PiHKAL in 1991. It was developed and tested by Darrell Lemaire, with publication via personal communication with Shulgin. The drug is a controlled substance in Canada under phenethylamine blanket-ban language.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1346149234 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

7 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.